Rehmann Capital Advisory Group’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $946K | Buy |
3,545
+315
| +10% | +$85.3K | 0.05% | 259 |
|
|
2025
Q4 | $812K | Buy |
3,230
+5
| +0.2% | +$1.33K | 0.04% | 282 |
|
|
2025
Q3 | $927K | Buy |
3,225
+50
| +2% | +$13.4K | 0.05% | 247 |
|
|
2025
Q2 | $833K | Buy |
3,175
+175
| +6% | +$42.6K | 0.05% | 252 |
|
|
2025
Q1 | $698K | Buy |
3,000
+62
| +2% | +$15K | 0.04% | 283 |
|
|
2024
Q4 | $674K | Buy |
2,938
+94
| +3% | +$21.6K | 0.04% | 281 |
|
|
2024
Q3 | $637K | Buy |
2,844
+53
| +2% | +$11.6K | 0.04% | 294 |
|
|
2024
Q2 | $568K | Sell |
2,791
-153
| -5% | -$31.1K | 0.04% | 305 |
|
|
2024
Q1 | $643K | Sell |
2,944
-296
| -9% | -$65.2K | 0.05% | 273 |
|
|
2023
Q4 | $736K | Sell |
3,240
-48
| -1% | -$10.1K | 0.06% | 238 |
|
|
2023
Q3 | $661K | Sell |
3,288
-2,879
| -47% | -$607K | 0.06% | 243 |
|
|
2023
Q2 | $1.28M | Sell |
6,167
-29
| -0.5% | -$5.63K | 0.11% | 143 |
|
|
2023
Q1 | $1.22M | Buy |
6,196
+1
| +0% | +$206 | 0.11% | 155 |
|
|
2022
Q4 | $1.25M | Sell |
6,195
-223
| -3% | -$43.6K | 0.13% | 140 |
|
|
2022
Q3 | $1.13M | Buy |
6,418
+19
| +0.3% | +$3.89K | 0.13% | 146 |
|
|
2022
Q2 | $1.29M | Sell |
6,399
-9
| -0.1% | -$1.92K | 0.14% | 131 |
|
|
2022
Q1 | $1.45M | Buy |
6,408
+4
| +0.1% | +$941 | 0.14% | 135 |
|
|
2021
Q4 | $1.73M | Sell |
6,404
-131
| -2% | -$32.4K | 0.16% | 111 |
|
|
2021
Q3 | $1.59M | Sell |
6,535
-1,528
| -19% | -$385K | 0.15% | 116 |
|
|
2021
Q2 | $1.91M | Buy |
8,063
+1,555
| +24% | +$354K | 0.18% | 92 |
|
|
2021
Q1 | $1.43M | Buy |
6,508
+116
| +2% | +$23.3K | 0.15% | 117 |
|
|
2020
Q4 | $1.12M | Sell |
6,392
-107
| -2% | -$18.5K | 0.13% | 137 |
|
|
2020
Q3 | $1.05M | Buy |
6,499
+25
| +0.4% | +$3.96K | 0.13% | 133 |
|
|
2020
Q2 | $925K | Buy |
6,474
+75
| +1% | +$10.4K | 0.13% | 145 |
|
|
2020
Q1 | $697K | Buy |
+6,399
| New | +$922K | 0.11% | 150 |
|
|
2019
Q3 | – | Sell |
-6,376
| Closed | -$947K | – | 1949 |
|
|
2019
Q2 | $947K | Buy |
6,376
+122
| +2% | +$17K | 0.12% | 140 |
|
|
2019
Q1 | $822K | Sell |
6,254
-113
| -2% | -$13.9K | 0.11% | 151 |
|
|
2018
Q4 | $691K | Buy |
6,367
+2,647
| +71% | +$355K | 0.1% | 104 |
|
|
2018
Q3 | $555K | Sell |
3,720
-18
| -0.5% | -$2.74K | 0.08% | 200 |
|
|
2018
Q2 | $576K | Buy |
3,738
+3,487
| +1,389% | +$526K | 0.08% | 189 |
|
|
2018
Q1 | $35K | Buy |
+251
| New | +$36.9K | 0.01% | 887 |
|
Other funds holding LH
VCM
VPM
Rehmann Capital Advisory Group's LH Position: Q1 2026 in Review
Rehmann Capital Advisory Group increased its Labcorp (LH) stake by 9.8% in Q1 2026, buying an estimated $85.3K and bringing the position to 3,545 shares worth $946K. The position accounts for 0.05% of the portfolio, ranked #259.
Rehmann Capital Advisory Group first reported a position in LH in Q1 2018 and has held it in 31 quarters since. The position peaked at $1.91M in Q2 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Rehmann Capital Advisory Group held 3,545 shares of Labcorp worth $946K as of Q1 2026.
- Rehmann Capital Advisory Group bought 315 Labcorp shares in Q1 2026, an estimated $85.3K.
- Labcorp made up 0.05% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #259 holding.
- Rehmann Capital Advisory Group first reported a position in Labcorp in Q1 2018 and has held it in 31 quarters since.
- Rehmann Capital Advisory Group's Labcorp position peaked at $1.91M in Q2 2021.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.